USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for USANA Health Sciences in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for USANA Health Sciences.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Linda Bolton Weiser DA Davidson	DA Davidson	Hold Maintains $38 → $36	Hold	Maintains	$38 → $36	+100.22%	Feb 27, 2025
Linda Bolton Weiser DA Davidson	DA Davidson	Hold Maintains $35 → $38	Hold	Maintains	$35 → $38	+111.35%	Jan 2, 2025
Linda Bolton Weiser DA Davidson	DA Davidson	Hold Maintains $38 → $35	Hold	Maintains	$38 → $35	+94.66%	Oct 23, 2024
Linda Bolton Weiser DA Davidson	DA Davidson	Hold Maintains $46 → $38	Hold	Maintains	$46 → $38	+111.35%	Jul 25, 2024
Linda Bolton Weiser DA Davidson	DA Davidson	Hold Maintains $48 → $46	Hold	Maintains	$48 → $46	+155.84%	May 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

957.51M

Increased by 3.49%

from 925.26M

Revenue Next Year

1.03B

Increased by 7.15%

from 957.51M

EPS This Year

1.99

Increased by 242.93%

from 0.58

EPS Next Year

2.83

Increased by 42.05%

from 1.99

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jan 1, 2022	Dec 31, 2022	Dec 30, 2023	Dec 28, 2024	Jan 3, 2026	Dec 31, 2026	Dec 31, 2027
Revenue	1.19B	998.60M	921.01M	854.50M	925.26M	957.51M	1.03B
Revenue Growth	4.57%	-15.83%	-7.77%	-7.22%	8.28%	3.49%	7.15%
EPS	5.73	3.59	3.30	2.19	0.58	1.99	2.83
EPS Growth	-2.22%	-37.35%	-8.08%	-33.64%	-73.52%	242.93%	42.05%
Forward PE	-	-	-	-	-	9.04	6.36
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	985.7M	1.1B
Avg	957.5M	1.0B
Low	920.0M	985.5M

Revenue Growth

Revenue Growth	2026	2027
High	6.5%	10.3%
Avg	3.5%	7.2%
Low	-0.6%	2.9%

EPS Forecast

EPS	2026	2027
High	2.05	2.91
Avg	1.99	2.83
Low	1.91	2.71

EPS Growth

EPS Growth	2026	2027
High	253.0%	46.2%
Avg	242.9%	42.1%
Low	229.5%	36.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.